Ameris Bancorp vs Renasant
ABCB and RNST side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABCB and RNST compare
Ameris Bancorp is the larger company, worth 1.5 times as much as Renasant ($5.5B against $3.6B).
On earnings, Renasant is cheaper: it trades at 11.2× trailing earnings, against 14.4× for Ameris Bancorp.
Renasant grew revenue faster over the last twelve months (25.7% versus 6.5% for Ameris Bancorp).
Ameris Bancorp keeps more of each dollar of sales as profit, with a net margin of 30.4% compared with 30.3% at Renasant.
Both pay dividends: Ameris Bancorp yields 0.97% and Renasant 2.4%.
Renasant scores higher on the StockData Score (21 against 12 for Ameris Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABCB | RNST |
|---|---|---|
| Size and price | ||
| Market cap | $5.5B | $3.6B |
| Share price | $82.50 | $39.91 |
| Change, 1 year | 10.1% | 14.7% |
| Change, 5 years | 59.9% | 4.9% |
| Beta (5Y) | 0.90 | 0.80 |
| Employees | 616 | 3,000 |
| StockData Score | ||
| Total score | 12 | 21 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 5 | 6 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 14.4× | 11.2× (better) |
| P/S | 4.4× | 3.3× (better) |
| P/B | 1.3× | 1.0× (better) |
| P/FCF | 8.7× | 8.4× (better) |
| PEG | 2.28 | – |
| FCF yield | 11.5% | 11.9% (better) |
| Fair value | $70.90 | $43.95 |
| Margin of safety | −16.4% | 9.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.5% | 25.7% (better) |
| Revenue growth, 5Y average | 2.2% | 8.3% (better) |
| Net income growth (TTM) | −3.0% | 127% (better) |
| EPS growth (TTM) | −0.87% | 79.4% (better) |
| EPS growth, 5Y average | 9.7% (better) | 6.9% |
| Profitability | ||
| Net margin | 30.4% (better) | 30.3% |
| FCF margin | 50.0% (better) | 39.6% |
| Return on equity | 9.5% (better) | 8.7% |
| Financial health | ||
| Debt / equity | – | 0.21 |
| Altman Z-score | 0.30 (better) | 0.20 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.97% | 2.4% (better) |
| Payout ratio | 14.1% | 26.4% |
| Years of dividend growth | 2 (better) | 1 |
| Dividend growth, 5Y average | 5.9% (better) | 0.23% |
| Buyback yield | 2.6% | 5.3% (better) |
| Shareholder yield | 3.6% | 7.6% (better) |
| Ownership | ||
| Held by institutions | 100.0% | 90.4% |
| Held by insiders | 5.8% | 2.1% |
| Insider net buying, 12 months | −$542K (better) | −$3.6M |
| Short interest, % of float | 4.0% | 5.6% |
Go deeper
- ABCB stock overview
- ABCB income statement
- ABCB valuation and score
- RNST stock overview
- RNST income statement
- RNST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.